Fortunately, earlier detection as a result of widespread prostate-specific antigen (PSA) testing and improved treatments mean that the majority of newly diagnosed prostate cancer patients will live for many years after their diagnosis [3], but with an expected increase in both incidence and years of life after diagnosis, the prevalence of prostate cancer will increase significantly in the future. The gene discussed is KLK3; the disease is prostate cancer.